Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda.

Among 233 children, Kaposi sarcoma-associated herpesvirus (KSHV) DNA was detected in 43% of children seropositive for both K8.1 and orf73, in 29% of children seropositive for K8.1 only, in 14% of children seropositive for orf73 only, and in 7% of children seronegative for both K8.1 and orf73; among 228 mothers, KSHV DNA was detected in 27%, 25%, 4%, and 1%, respectively. KSHV DNA was detected more frequently and at higher levels in saliva than in buffy-coat samples and in children than in mothers. In both children and mothers, detection in saliva was associated with detection in peripheral blood. Detection was associated with K8.1 seropositivity, younger age, and high household density, indicating the importance of in-household person-to-person transmission, likely via saliva.

[1]  R. Biggar,et al.  Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. , 2004, The Journal of general virology.

[2]  J. Goedert,et al.  Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. , 2003, Journal of the National Cancer Institute.

[3]  Jeffrey N. Martin,et al.  Diagnosis and epidemiology of human herpesvirus 8 infection. , 2003, Seminars in hematology.

[4]  F. Mhalu,et al.  Detection of human herpesvirus 8 DNA in serum from blood donors with HHV‐8 antibodies indicates possible bloodborne virus transmission , 2002, Journal of medical virology.

[5]  E. Nicastri,et al.  Primary human herpesvirus 8 infection in immunocompetent children. , 2002, JAMA.

[6]  J. Goedert,et al.  Prevalence of Kaposi's sarcoma‐associated herpesvirus infection in sex workers and women from the general population in Spain , 2002, International journal of cancer.

[7]  A. Wald,et al.  HHV‐8 infection: a model for reactivation and transmission , 2002, Reviews in medical virology.

[8]  W. Klaskala,et al.  Vertical transmission of Kaposi's sarcoma‐associated herpesvirus , 2001, International journal of cancer.

[9]  A. Blauvelt,et al.  Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. , 2001, Blood.

[10]  W. Miley,et al.  A quantification of human cells using an ERV-3 real time PCR assay. , 2001, Journal of virological methods.

[11]  A. Wald,et al.  Mucosal shedding of human herpesvirus 8 in men. , 2000, The New England journal of medicine.

[12]  R. Biggar,et al.  Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. , 2000, The Journal of infectious diseases.

[13]  G. de Thé,et al.  Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa , 1999, International journal of cancer.

[14]  L. Corey,et al.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma , 1997, Journal of virology.

[15]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.